FSBI "N.N Blokhin Med.Res.Cent.Onc."MoH of RF

Moscow 115478

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Leukemia, Myeloid, Acute, Mesothelioma

Studies at this site

• Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) — Completed
• Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early